Cystic fibrosis newborn screening: shifting the key question from "should we screen?" to "how should we screen?".
Farrell
Philip M
PM
Department of Pediatrics, University of Wisconsin Medical School, Madison, WI 53706, USA. pmfarrel@facstaff.wisc.edu
D003550:Cystic Fibrosis / Q000175:diagnosis* / Q000235:genetics; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics*; D004252:DNA Mutational Analysis; D006801:Humans; D007231:Infant, Newborn; D009154:Mutation; D015997:Neonatal Screening / Q000379:methods*; D014362:Trypsinogen / Q000097:blood*
C505032:CFTR protein, human; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D014362:Trypsinogen